Sign in

CIK 0001398733

  • Non-accelerated filer
  • Smaller reporting company

Aquestive Therapeutics, Inc.

Sign in to watch
Ticker
AQST
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
208623253
Phone
+1 908-941-1900
Business address
184 LIBERTY CORNER ROAD, SUITE 305, WARREN, NJ
Former names
MonoSol Rx, Inc.
Open-market buys, last 90 days
$99,331
in 1 filing
Open-market sales, last 90 days
$297,289
in 4 filings, $297K under 10b5-1 plans

Net −$197,958. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2020-08-18 Maxwell John T. SVP-Chief Financial Officer Sale −3,000 $8.00 $24K 150,614
2020-03-16 Maxwell John T. SVP-Chief Financial Officer Grant or award · Non-Qualified Stock Option (right to buy) +60,000 60,000
2019-02-28 Maxwell John T. SVP-Chief Financial Officer Grant or award · Non-Qualified Stock Option (right to buy) +95,000 95,000
2018-12-06 Maxwell John T. SVP-Chief Financial Officer Purchase +5,000 $8.87 $44K 153,614
2018-11-21 Maxwell John T. SVP-Chief Financial Officer Purchase +10,000 $9.80 $98K 148,614
2018-07-24 Maxwell John T. SVP-Chief Financial Officer Grant or award · Stock Option (Right to Purchase) +36,120 36,120

Page 1 of 1 · 6 trades